






























hJournal of Virological Methods 193 (2013) 364– 370
Contents lists available at ScienceDirect
Journal  of  Virological  Methods
jou rn al hom epage: www.elsev ier .com/ locate / jv i romet
eal-time  cell  analysis  –  A  new  method  for  dynamic,  quantitative
easurement  of  infectious  viruses  and  antiserum
eutralizing  activity
heng  Teng,  Xiaozhou  Kuang,  Jiayu  Wang,  Xi  Zhang ∗
epartment of Microbiology, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
rticle history:
eceived 12 April 2013
eceived in revised form 19 June 2013
ccepted 26 June 2013
vailable online 5 July 2013
eywords:
CTA
a  b  s  t  r  a  c  t
A  newly  developed  electronic  cell  sensor  array  – the  xCELLigence  real-time  cell  analysis  (RTCA) sys-
tem  is  tested  currently  for  dynamic  monitoring  of  cell  attachment,  proliferation,  damage,  and  death.
In  this  study,  human  enterovirus  (HEV71)  infection  of  human  rhabdomyosarcoma  (RD)  was  used  as an
in  vitro  model  to  validate  the  application  of  this  novel  system  as  a straightforward  and  efﬁcient  assay  for
quantitative  measurement  of infectious  viruses  based  on  virus-induced  cytopathic  effect  (CPE).  Several
experimental  tests  were  performed  including  the determination  of  optimal  seeding  density  of the  RD
cells  in  96-well  E-plates,  RTCA  real-time  monitoring  of  the  virus  induced  CPE  and  virus  titer  calculation,EV71
CID50
iral assay
and  viral  neutralization  test  to determine  HEV71  antibody  titer.  Traditional  50%  tissue  culture  infective
dose  (TCID50) assay  was  also  conducted  for  methodology  comparison  and  validation,  which  indicated
a  consistent  result  between  the  two  assays.  These  ﬁndings  indicate  that  the xCELLigence  RTCA  system
can  be  a valuable  addition  to  current  viral  assays  for quantitative  measurement  of  infectious  viruses and
quantitation  of  neutralization  antibody  titer  in  real-time,  warranting  for  future  research  and  exploration
of applications  to  many  other  animal  and  human  viruses.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.. Introduction
Since the discovery and identiﬁcation of viruses in the late
9th century (Levy, 1994), numerous viruses have been reported
o cause a variety of diseases among humans, animals, and plants
Levy, 1994). Since viruses are obligate intracellular pathogens, the
solation, propagation, and study of viral pathogens and new iso-
ates are largely dependent on the availability of a live host system,
uch as in vitro cell cultures. Currently, viruses are commonly iden-
iﬁed by using molecular technology like PCR and RT-PCR. However,
onﬁrmative diagnosis and quantitation of infectious viruses are
till dependent on traditional infectivity methods using permis-
ive cell lines established in vitro; including viral plaque assay and
edian tissue culture infective dose (TCID50) assays.
Viral PFU assay is known to be an enumerative quantitation
ethod used to measure infectious viruses by counting the number
f plaques produced in the monolayer of permissive cells within a
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Open access under CC BY license.semisolid medium that restricts progeny viruses from being relea-
sed to neighbor cells. In contrast, TCID50 assay is a quantitation
method that uses microscopic observation of viral induced cyto-
pathic effect (CPE) to determine the endpoint dilution of a virus
causing 50% cell death or CPE of inoculated cells. Between these
two virus infectivity assays, the end-point dilution based TCID50
assay is used more commonly. Particularly, in clinical research for
the determination of the lethal dose of pathogenic viruses and
viruses like retroviruses which infect and replicate in host cells
without killing them, resulting in no plaques in liquid and semisolid
medium. This method is based primarily on the endpoint dilution
to determine the amount of viruses required to kill 50% of test cells
or to produce CPE in 50% of tested cell cultures. This method of
viral quantitation requires manual observation and recording of
all affected wells using an inverted phase contrast microscope to
calculate the TCID50 titer based on the end-point dilution.
The xCELLigence system RTCA, developed by Roche Applied
Science, uses microelectronic biosensor technology to do dynamic,
real-time, label-free, and non-invasive analysis of cellular events,
including cell number change, cell adhesion, cell viability, cell mor-
phology, and cell motility (Solly et al., 2004; Atienza et al., 2006;
Fang et al., 2011; Irelan et al., 2011; Ke et al., 2011; Moodley et al.,
2011). With the increased attention to cell-mediated cytotoxicity,
virus-mediated cytotoxicity, and proﬁling tumor cell response to








































rig. 1. xCELLigence system (RTCA). xCELLigence system (RTCA) is composed of a
ontrol unit, analyzer, E-plate 96, and Sp station.
reatment, this RTCA system presents a unique, impedance-based
ystem for cell-based assays; allowing for label-free and real-time
onitoring of cellular processes such as cell growth, proliferation,
ytotoxicity, adhesion, morphological dynamics, and modulation
f barrier function. This system has been used recently in monito-
ing virus infection and virus-induced cytopathology (Yama et al.,
009; Fang et al., 2011; Yian et al., 2012). To determine the feasi-
ility and efﬁciency of this new technology in virology, the RTCA
ystem was also tested for possible quantitation of infectious virus
iters based on cell viability and morphology changes. In this study,
uman enterovirus type 71 (HEV71) infection of RD cells was used
s an in vitro model in comparison to traditional TCID50 viral assay
o validate the RTCA method.
. Materials and methods
.1. xCELLigence system (RTCA)
The xCELLigence RTCA SP system is composed of four compo-
ents: a computer, electronic sensor analyzer, workstation, and
6-well microtiter detection device (Fig. 1). The microelectrode
ensor arrays are coated in 96-well microtiter plates and the micro-
iter plate detection device is connected to the workstation from
he inside of the cell culture incubator. A cable connects the works-
ation to the sensor analyzer for impedance measurement. The
mpedance data from the selected wells is exported to the com-
uter and analyzed using RTCA software. A parameter termed cell
ndex is used to quantify cell status based on detected cell-electrode
mpedance. Cell attachment and proliferation from selected wells
f the plate were monitored and recorded every 15 min  using the
TCA SP.
.2. Cell and virus
The human rhabdomyosarcoma (RD) cell line was obtained from
he National Polio Laboratory in China and employed for human
nterovirus type 71 (HEV71) replication and infectivity assay. RD
ells were propagated and maintained at 37 ◦C with 5% CO2 with
agle’s Minimum Essential Medium (Eagle’s MEM, GIBCO) supple-
ented with 10% fetal bovine serum (FBS). RD cells were harvested
t their exponential growth phase using 0.25% trypsin–EDTA diges-
ive solution and used for viral infectivity tests.A HEV71 stock was obtained from the National Polio Labora-
ory in China and used as a reference virus to test and establish
he RTCA based viral infectivity measurement. The HEV71 refe-
ence strain was prepared from one patient infected with HFMDethods 193 (2013) 364– 370 365
during the HEV71 outbreak in Anhui province in 2008. This
particular HEV71 isolate is known to induce visible CPE in the RD
cells following a short period of viral infection (Chua et al., 2008).
Therefore, the HEV71–RD cell system is designed as an in vitro
model to assess whether the RTCA SP system can be used as a
viral assay to measure viral infectivity and infectious dose; through
comparison with virus titer determined by currently used (TCID50)
assay. The calculation of viral TCID50 value was conducted using
the method described by Reed–Muench method (1938).
2.3. Antiviral HEV71 sera
A viral neutralization assay was also performed in this study
using positive anti-HEV71 sera obtained from three individuals
who were conﬁrmed with HEV71 infection in 2008 (unpublished
data from this laboratory). The neutralization test was  performed
to determine if the RTCA SP-based viral assay system can be used to
effectively measure antibody mediated viral neutralization activity.
2.4. Optimized cell density for RTCA
To establish a background reading for the RTCA system, 100 L
of growth media containing 10% FBS was added to each well of
the 96-well E-plates and tested. Then, 100 L/well of 2-fold serial
dilutions of RD cell suspensions with cell density ranging from
7.5 × 103 to 6.0 × 104 cells/well were seeded into the E-plate. An
additional 100 L/well of the growth medium was  added to the E-
plate for a total volume of 200 L/well before plating the plates at
37 ◦C incubators with 5% CO2. Cell growth status from each E-plate
were monitored every 15 min  and cell index values were calculated
and expressed accordingly based on observing dynamic cell growth
curves during post-growth time.
Meanwhile, the same preparation of RD cell suspension was also
seeded into a regular 96-well plate (Nunclon) at 200 l/well of cell
suspension containing 4 selected cell densities (from 7.5 × 103 to
6.0 × 104 cells/well). Cell attachment and growth were examined
using phase contrast inverted microscopy as a parallel comparison.
Eight replicate wells were used for each seeded cell density and
three experimental tests were independently conducted in order
to determine an optimal cell seeding density in cell attachment
and viability for a total of 6 days, the time required to complete the
HEV71 infectivity test.
2.5. Viral infectivity assay
RD cells at their exponential growth phase were harvested using
trypsin–versene solution and individual cell suspensions were pre-
pared at a cell density of 1.5 × 104 cells/mL. RD cells were then
seeded into an E-96-well plate at 100 L/well and incubated at
37 ◦C to allowed cell attachment and formation of a cell monolayer.
A HEV71 viral stock was  diluted 10-fold with Eagle’s MEM  and
used for a viral infectivity assay. According to pre-experimentally
determined dynamic cell proliferation, 100 L/well of diluted
HEV71 was  added to the E-plate at 8 replicate wells per viral dilu-
tion. In addition, the same volume of growth medium was  added
to the cell cultures as mock-infected control wells. After 90 min of
viral adsorption at 37 ◦C, the test cells were supplemented with
100 L/well of Eagle’s MEM  growth media containing 5% FBS, and
then incubated 37 ◦C. Infectious viral titers were determined based
on cell index values obtained through the RTCA system.
As a parallel comparison, the same 10-fold dilutions of HEV71
samples were tested and tittered by infecting RD cells grown
in normal 96-well cell culture plates at 100 L/well and 8 wells
per dilution. Infected cultures were incubated at 37 ◦C and viral-
induced cytopathic effect (CPE) was  monitored daily using inverted
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nfectivity test was terminated and infectious viral titers were cal-
ulated as TCID50 units based on viral induced CPE.
.6. Viral neutralization assay
To validate and explore the possible use of RTCA as a real-time
onitoring tool for viral infectivity, a viral neutralization test was
erformed using anti-HEV71 serum samples collected in 2008. In
his test, the anti-HEV71 sera were inactivated with 56 ◦C water
ath for 30 min. Then, 2-fold serial dilutions of the sera ranging
rom 1:2 to 1:32 were performed with Eagle’s MEM  containing
o FBS. To determine the viral neutralization titer, each diluted
erum solution was mixed with an equal volume of a pre-diluted
iral stock containing 100 TCID50/mL  of HEV71. The resulting mix-
ure was incubated at 37 ◦C along with both positive (viral solution
lone) and negative (dilution medium alone) controls under the
ame experimental conditions. At the end of a 90 min  incubation,
ach serum–virus mixture was inoculated into both the 96-well E-
lates and regular 96-well cell culture plates seeded with RD cell
t 1.5 × 104 cells/well, 19 h prior to viral inoculation at 100 l/well
nd 4 replicated wells per mixture. The infected cultures were
ncubated at 37 ◦C with 5% CO2 and continually monitored using
TCA software and cell index values were documented. Viral neu-
ralization titer of these three serum samples were deﬁned as the
eciprocal of the highest dilution of these sera which caused the
omplete blockage of viral infectivity of 100 TCID50 HEV71 in all the
est wells. The same mixtures of serum–virus dilutions were also
ested for viral neutralization activity using traditional TCID50 viral
nfectivity assays, and serum-mediated viral neutralization titers
ere determined based on microscopic observation of infected cell
ig. 2. (A) The density of cells titration based on RTCA. Four densities of RD cells were see
y  measuring the CI to identify a suitable time point for viral infectivity. The adhesion 
TCA  SP Instrument. The colored curves indicate the average CI of different cell densities
1.5  × 104/well) were seeded into the 96-well plate (Nunclon) as a parallel comparison be
10×).  (For interpretation of the references to color in this ﬁgure legend, the reader is refeethods 193 (2013) 364– 370
cultures for viral induced CPE. A comparative analysis was conduc-
ted between the two methods for viral neutralization effect from
the three sera samples.
3. Results
3.1. Optimal density for cell proliferation and viability
To facilitate the use of the RTCA SP system as a biological tool to
measure viral infectivity, it requires ﬁrstly establishing optimized
seeding densities for test cells. Cell impedance was  measured from
each individual well of a 96-well E-plate and was  automatically
converted to cell index values by the RTCA Software. The cell index
value represents a quantitative measure of the growth status of the
test cells. Under the same test conditions, increased cell attachment
in an E-plate well was detected by the electrodes leading to a rela-
tively large value of cell index. Furthermore, even when the same
number of cells was seeded in the wells of an E-plate, a detected
change in the cell index value can be an indication of a different
rate of cell growth.
To determine an optimal seeding density of test cells to
be used for the RTCA system, RD cells were seeded into the
E-plates in four different densities ranging from 7.5 × 103 to
6.0 × 104 cells/well. Respective impedance was determined and
shown in Fig. 2A. The cell index values from the wells with 6.0 × 104
and 3.0 × 104 cells/well settings showed a decrease at post growth
time 85 h and 119 h, respectively. However, at the seeding density
of 1.5 × 104 cells/well, the cell index value continued to be increa-
sed and reached its highest point at 151 h post growth. In contrast,
the cell index value from the well seeded with 7.5 × 103 cells/well
ded in the E-plate of 96 wells with 8 replicated wells and continuously monitored
and proliferation of RD cells were dynamically monitored every 15 min using the
 seeded per well in an E-plate. (B) Cell status observation via microscopy. RD cells
ing observed from the second day to the sixth day after cell seeding by microscope
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ontinued to be increased up to 170 h, but at a relatively low level.
hus, the optimal seeding density of RD cells for this study was
etermined to be 1.5 × 104 cells/well.
In comparison with the same seeding density of RD cells
1.5 × 104 cells/well) in normal, 96-well plates, cell growth status
as monitored daily using inverted microscopy (Fig. 2B). RD cells
howed good attachment and growth for up to 6 days, which is
ig. 3. HEV71 induced cytopathogenicity. Dynamic monitoring of RD cells during HEV71
as  monitored by measuring cell impedance every 15 min using the RTCA SP Instrume
egarded  151 h as the endpoint of our results. Each dilution was done in 8 replicate wel
ells  continued to decline and the CI of the 4 other wells were similar to the cell grow
EV71-infected RD cells at 151 h. (For interpretation of the references to color in this ﬁguethods 193 (2013) 364– 370 367
comparable with the experimental ﬁndings obtained from the RTCA
SP system by measuring cell index values.3.2. HEV71 infectivity
When the test cells were monitored using the RTCA system,
a clear correlation was  noted between the amount of infectious
 infection (A) the HEV71 mediated effect on adhesion and proliferation of the cells
nt. The black vertical line indicates the time HEV71 was added (19 h) and (B) we
ls. The CI from each well infected with a 10−4 dilution were observed, the CI of 4
th curve. (C) Phase contrast microscopy (10×) illustrates cytopathic effect in the
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irus inoculated and detected changes of CELL INDEX values. As
hown in Fig. 3A, while the cell index value from the noninfec-
ed wells remained increased up to 151 h, affected wells showed a
iral dose-dependent faster decline of cell index values. This diffe-
ence signiﬁes the occurrence of cell apoptosis. The magenta curve
hows the average cell index of the growth of unaffected cells with
51 h considered as the endpoint for test analysis. Compared to
he control wells, the average cell index of RD cells infected with
he 10−5 dilution of HEV71 showed a similar pattern to the control
ells, despite a notably slightly lower level (Fig. 3A, purple curve).
n contrast, the average cell index of cells infected with the 10−3
ilution began to decline at approximately 89 h post virus infec-
ion (Fig. 3A, red curve), and dropped dramatically afterward. This
attern of decline in cell index values was detected in all 8 wells
nfected with the 10−3 virus dilution (data not shown). The average
ell index of cells infected with the dilution of 10−4 HEV71 began to
ecline at approximately 100 h following virus inoculation (Fig. 3A,
ig. 4. Dynamic monitoring of neutralizing activity of diluted antiserum samples. The v
easuring cell impedance every 15 min  using the RTCA SP Instrument. The ﬁnal dilution 
ine  indicates when the virus was  added (19 h). Results are the average of 4 replicate welethods 193 (2013) 364– 370
green curve). We  determined that the dilution of 10−4 virus appea-
red to be the dilution closest to the endpoint of infectious HEV71,
and thus, the average cell index curves were characterized from
each of the eight, individual wells infected with the 10−4 dilution.
As shown in Fig. 3B, while a similar pattern of cell index curves
were observed from 4 wells, the other 4 wells showed a continued
decline of the average cell index values after post infection time
of 151 h. These observations allowed us to determine the TICD50
titer of the HEV71 stock which was  calculated as: inoculum volume
(mL) × 104.
Titration of the HEV71 stock was also conducted using a regular
96-well plate for traditional TCID50 assays as a parallel comparison
and the experimental results were shown in Fig. 3C. The control
cells appeared healthy with good cell attachment at post growth
time of 151 h. However, cells infected with the 10−4 viral dilution
showed viral-induced CPE in approximately half of the 8 wells at
151 h post infection time, while all the 8 wells infected at 10−3 virus
irus-mediated effect on adhesion and proliferation of the cells was monitored by




























































vZ. Teng et al. / Journal of Virolo
ilution showed viral induced CPE. Therefore, the HEV71 virus stock
as a TCID50 titer falling to the dilution of 10−4.
.3. Neutralizing antibody test
In this study, the possible use of RTCA SP to determine neutra-
ization titer of unknown anti-sera was also explored. Particularly,
his study deﬁned the neutralization antibody titer as the reciprocal
f the lowest concentration of test sera showing complete blockage
f the viral infectivity of 100 TCID50 HEV71 in all the test wells of
D cells. Compared to the controls, a similar pattern of the average
ell index of cell growth was observed for sera #1 and #3 at dilu-
ions of 1:4 and for serum #2 at 1:2 dilution (Fig. 4A–C). Apparent
ecline of the cell index values were observed when the sera was
urther diluted to 1:4 (serum 2) and 1:8 (sera 1 and 3). According to
he CI curves, the neutralization antibody titer in serum 1, serum 2,
nd serum 3, were determined to be 4, 2, and 4, respectively. The
verage cell index curve from the RD cells exposed to the dilutions
f these sera alone showed no difference to the cell controls, indi-
ating no cytotoxic effect of these three serum samples (data not
hown).
Additionally, Fig. 4 showed the time of onset of the average
ecrease of cell index values for serum 1 at 98 h, serum 2 at 75 h, and
erum 3 at 106 h post viral infection. According to the delayed time
or cell death, serum 3 exhibited the highest viral neutralization
ctivity while serum 2 was the lowest.
. Discussion
In vitro cultivation of animal cells has become an extremely
mportant and essential biological tool for the study of animal and
uman viruses today. Currently, many cell lines have been establi-
hed from the tissues and organs of various animal species (Barron
t al., 1970; Wolf and Mann, 1980; Fryer and Lannan, 1994; Lu
t al., 1999, 2001; Rougee et al., 2007; Lakra et al., 2011). These
ell lines are widely used for virus isolation, characterization, and
tudies (Menna et al., 1975; Lifson et al., 1986; Smith et al., 1986;
ayment and Trudel, 1994; Shimizu et al., 1994; Lu et al., 1997,
003; Leland and Ginocchio, 2007; Ilarraza et al., 2011; Rice, 2011;
ainz et al., 2012), and other related studies including antiviral
rug screening (Yasuhara-Bell et al., 2010; Wozniak et al., 2011;
ong et al., 2012) and preparation of attenuated anti-viral vaccines
Barrett et al., 2009; Liu et al., 2009; George et al., 2010; Monath
t al., 2011; Ilyushina et al., 2012; Perdue et al., 2011; Lohr et al.,
012). Since virus infection of in vitro cells cultures can lead to
isible cellular damage and death (CPE), this virus infection cha-
acteristic has been utilized for the detection of viral pathogens
nd the quantitation of infectious virus titers through limited end-
oint dilution tests. Among the methods for viral titration, TCID50
ssay is considered rapid and readily reproducible since semisolid
verlay medium or speciﬁc antibody conjugate are not required.
espite the limitation of tedious manual examination of each indi-
idual well for virus infection (CPE), TCID50 is widely used today for
he titration of many animal viruses including clinical virus quan-
itation where the lethal dose of virus must be determined since
eing established in 1938 (Reed and Muench, 1938).
In the present study, the possible use of the new xCELLigence
TCA system as a tool to quantify infectious virus was  evaluated
y measuring the change of cell-electrode impedance of HEV71
nfected RD cells. This application of the RTCA system in virology is
ased on the understanding that cell-electrode impedance is pri-
arily inﬂuenced by three factors; cell numbers, cell morphology,
nd cell adhesion to the electrode surface. Productive infection of
athogenic viruses such as HEV71 is known to induce cell damage
nd death (CPE) resulting in decreased number of test cells that can
isualized under inverted microscope. These cellular death eventsethods 193 (2013) 364– 370 369
and cell population changes could also be readily detected using the
RTCA system which reﬂects the decreased level of cell-electrode
impedance. Such changes form the basis of using the RTCA system
to detect and measure the infectious titer of a test virus.
Unlike traditional tests which measure viral infectivity based
on microscopic observations of viral induced CPE, the RTCA system
mediated viral infectivity measurement is based on the cell growth
curve as determined by changes in cell index. In particular, each
cell index change indicates changes of cell status in each well and
these two  parameters can be used to reﬂect the magnitude of viral
induced CPE: one parameter was the onset time point when cell
index values begin to decrease, and the other was the cell index
curve of affected cell cultures. By comparing these parameters to
the cell index values and curves of uninfected control cells, no viral
infectivity was determined when the cell index curve from an indi-
vidual well/sample is similar to that observed in the control cell
cultures. In contrast, when test cells shows an earlier decline of the
cell index curve as compared to control cells, this suggested the
occurrence of active viral infection of the cultures. Furthermore, a
large decrease of cell index or dramatic decline of the cell index
curve indicated the presence of a massive virus infection in the
cell cultures. Monitoring and analysis of the cell index curves could
be done on individual wells with respect to time and this forms
the basis to calculate the titers of test viruses and/or neutralization
antibody titer by measuring the number of wells showing the cell
index declined. Infectious titer of a virus stock can be calculated
similarly according to the Reed–Muench method based on detec-
ting the change of cell index values using a computer instead of
detecting viral induced CPE via inverted microscopy.
To establish the xCELLigence RTCA system as tool for effec-
tive measurement of virus infection and quantitation of infectious
viruses, three independent experimental tests were conducted
using HEV71–RD cells as a model, including the use of the RTCA
system to quantify the infectious titer of a HEV71 stock through
measuring electronic impendence; and titration of the same virus
dilution using traditional TCID50 assay so the infectious titer of
the virus stock can be compared and validated between these two
methods. Results obtained from this study have clearly shown
that the infectious titer of the HEV71 stock detected from these
two methods is in complete agreement. Despite the limitation of
present testing with one virus strain (HEV71), ﬁndings from this
study have clearly demonstrated the potential and application of
the RTCA system to many other human viruses for quantitation
as long as they are able to induce a productive infection in their
permissive cell cultures. A major advantage of the RTCA system in
virus titration testing is the ability of the system to monitor and
measure virus-induced cell damage and death in a very dynamic
fashion which is easy and convenient. Speciﬁcally, since each well
can be precisely monitored and visualized through a computer, this
eliminates the need to manually check each individual wells using
an inverted phase contrast microscope. It should be noted that the
high cost of purchasing and operation of the RTCA system may be
a signiﬁcant limitation. However, the exploration and extension
of its use to virology may  be a cost-effective application in situa-
tions where this system is currently available for other cell-based
assays.
Before conducting the cytopathic assay, an initial test for quan-
titative analysis of cell proliferation was carried out using the RTCA
system to determine the optimal density for cell seeding. This
test demonstrated that 1.5 × 104 cells/well was the optimal seeding
density for E-plates with RD cells to be used for HEV71 infections.
At this density, seeded RD cells showed no obvious decrease of cell
index for approximately 151 h, which meets the 6-day requirement
for HEV71 to induce a detectable cytopathic change in RD cells.
It should be pointed out that since the productive infection time
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re-test for cell seeding density for a particular virus-cell infection
ystem is required when using the RTCA system.
In this study, the neutralization antibody titer and the time of
nset of CPE were recorded in a real-time manner. In addition,
ven though the neutralization titer can be the same for the three
ifferent antiserum samples, the onset time of neutralization acti-
ities on virus inactivation have different impedance curves (i.e.
erum samples 1 & 3 in Fig. 4). Therefore, traditional methods are
ot just laborious and difﬁcult for high throughput detection, it
s also incapable of detecting the onset time of virus-induced and
ntiserum-mediated cellular change.
In summary, the RTCA SP system was assessed to be a useful tool
or quantitation of infectious virus and testing the neutralizing acti-
ity of serum. The RTCA system provides the opportunity to screen
erum samples in a high throughput environment, by reducing ove-
all workload and the laborious task of manual examination of test
ells for the presence/absence of virus-induced cytopathic effects
nd neutralizing activity.
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